Search research articles
Contact Us
Filters
Showing results (571-580 of 704) with videos related to
Page
of 71
Sort By:
Nature Medicine
|
May 16, 2023
Neoadjuvant immunotherapy for melanoma is now ready for clinical practice
Claus Garbe, Reinhard Dummer, Teresa Amaral, et al.
Nature Communications
|
February 19, 2021
Tumour gene expression signature in primary melanoma predicts long-term outcomes
Manik Garg, Dominique-Laurent Couturier, Jérémie Nsengimana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2020
Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma
Ailin Lepletier, Jason Madore, Jake S O'Donnell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 27, 2015
Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms
Douglas B Johnson, Alexander M Menzies, Lisa Zimmer, et al.
The New England Journal of Medicine
|
November 18, 2014
Nivolumab in previously untreated melanoma without BRAF mutation
Caroline Robert, Georgina V Long, Benjamin Brady, et al.
The Lancet. Oncology
|
October 20, 2022
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716): distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial
Georgina V Long, Jason J Luke, Muhammad A Khattak, et al.
JAMA Surgery
|
February 9, 2022
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma
Irene L M Reijers, Robert V Rawson, Andrew J Colebatch, et al.
Genome Medicine
|
May 11, 2021
Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysis
Sunny Z Wu, Daniel L Roden, Ghamdan Al-Eryani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 12, 2024
Outcomes following long-term disease control with immune checkpoint inhibitors in patients with advanced melanoma
Eleanor E Handel, Janet McKeown, Joe Wei, et al.
JAMA Network Open
|
February 16, 2024
Health Economic Consequences Associated With COVID-19-Related Delay in Melanoma Diagnosis in Europe
Lara V Maul, Dagmar Jamiolkowski, Rebecca A Lapides, et al.
Page
of 71
Search research articles
Search
Showing results (571-580 of 704) with videos related to
Sort By:
Page
of 71
Nature Medicine
|
May 16, 2023
Neoadjuvant immunotherapy for melanoma is now ready for clinical practice
Claus Garbe, Reinhard Dummer, Teresa Amaral, et al.
Nature Communications
|
February 19, 2021
Tumour gene expression signature in primary melanoma predicts long-term outcomes
Manik Garg, Dominique-Laurent Couturier, Jérémie Nsengimana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2020
Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma
Ailin Lepletier, Jason Madore, Jake S O'Donnell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 27, 2015
Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms
Douglas B Johnson, Alexander M Menzies, Lisa Zimmer, et al.
The New England Journal of Medicine
|
November 18, 2014
Nivolumab in previously untreated melanoma without BRAF mutation
Caroline Robert, Georgina V Long, Benjamin Brady, et al.
The Lancet. Oncology
|
October 20, 2022
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716): distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial
Georgina V Long, Jason J Luke, Muhammad A Khattak, et al.
JAMA Surgery
|
February 9, 2022
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma
Irene L M Reijers, Robert V Rawson, Andrew J Colebatch, et al.
Genome Medicine
|
May 11, 2021
Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysis
Sunny Z Wu, Daniel L Roden, Ghamdan Al-Eryani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 12, 2024
Outcomes following long-term disease control with immune checkpoint inhibitors in patients with advanced melanoma
Eleanor E Handel, Janet McKeown, Joe Wei, et al.
JAMA Network Open
|
February 16, 2024
Health Economic Consequences Associated With COVID-19-Related Delay in Melanoma Diagnosis in Europe
Lara V Maul, Dagmar Jamiolkowski, Rebecca A Lapides, et al.
Page
of 71